Chia seed supplementation improved systolic blood pressure in people with type-2 diabetes

Not Applicable

Completed

• Conditions: - blood pressure- fasting glucose, insulin, HbA1c and lipid profile- body weight changes; Chia seeds, blood pressure, glycated hemoglobin, body weight

• Registration Number: TCTR20190727003
• Lead Sponsor: Kuwait University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-03-25
• Study Start: 2019-07-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

- T2DM patients age (21-65) years
- Stable renal function in the last 6 months prior to the study.
- Stable dose of medication for the past 3 months.
- Female of childbearing age must have effective contraceptive during the trial.
- Patients on oral hypoglycemic agents and a single insulin dose (basal insulin).

Exclusion Criteria

- Those have intolerance or allergy to the product.
- Pregnant women.
- Patients with end-stage complications.
- Multiple insulin dosage.
- Newly diagnosed Type 2 Diabetes.
- Patients taking Aspirin and warfarin to avoid any possible interaction or thinning effect from n-3 PUFA in the chia seeds.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glycated Hemoglobin, Fasting blood Glucose and Insulin baseline and end of experiment, 12 weeks blood tests for fasting glucose insulin and HbA1c

Secondary Outcome Measures

Name	Time	Method
Blood Pressure and Plasma Lipids Baseline and end of experiment, 12 weeks routine lab procedures